Timothy Corson, Ph.D.
Indiana University School of Medicine
Chair, Department of Pharmacology & Toxicology
https://medicine.iu.edu/
(317) 2743305
[email protected]
Sustained release griseofulvin microparticles offer longterm therapy for
choroidal neovascularization in a preclinical model Also, Targeting Ref1 protein with APX3330 drug is possible oral treatment for AMD
#AMD #maculardegeneration #griseofulvin #apx3330 #indianauniversity #timcorson #choroidalneovascularization #clinicaltrials